Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Kering symbols : Atha save search
Athira Pharma Reports Second Quarter 2022 Financial Results and Recent Clinical and Corporate Updates
Published: 2022-08-15 (Crawled : 01:00) - biospace.com/
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: 2.74%
H: 0.0%
C: -0.69%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: -1.23%
H: 0.33%
C: 0.16%
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: -0.77%
H: 1.81%
C: 0.78%
pharma results
Athira Issues Statement in Response to Richard A. Kayne’s Suspension of His Proxy Contest
Published: 2022-05-16 (Crawled : 21:00) - globenewswire.com
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: 3.5%
H: 5.36%
C: -0.64%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: 3.3%
H: 0.04%
C: 0.0%
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: 1.5%
H: 5.28%
C: 1.36%
response
Leading Independent Proxy Advisory Firm ISS Recommends that Athira Shareholders Vote on Athira’s WHITE Proxy Card
Published: 2022-05-04 (Crawled : 23:00) - globenewswire.com
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: -0.02%
H: 1.5%
C: -3.44%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: -3.04%
H: 0.04%
C: -2.57%
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: -0.56%
H: 0.94%
C: -5.75%
Athira Files Investor Presentation Highlighting Successful Execution of its Strategy and Highly Qualified Board and Leadership
Published: 2022-04-26 (Crawled : 18:00) - globenewswire.com
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: 1.28%
H: 0.0%
C: -3.42%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: 0.31%
H: 0.0%
C: -2.91%
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: -0.96%
H: 2.75%
C: -2.48%
presentation
Athira Mails Letter to Shareholders Highlighting the Strength of its Board and Record of Deliberate Board Refreshment
Published: 2022-04-20 (Crawled : 13:20) - globenewswire.com
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: 2.41%
H: 0.17%
C: -1.43%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: 2.38%
H: 0.22%
C: -0.88%
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: 3.15%
H: 3.93%
C: 1.48%
Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update
Published: 2022-03-24 (Crawled : 23:00) - biospace.com/
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: -0.87%
H: 0.0%
C: -4.31%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: -0.25%
H: 0.85%
C: 0.82%
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: 0.53%
H: 6.19%
C: 5.04%
pharma results
Athira Pharma Announces Appointment of Grant Pickering to its Board of Directors
Published: 2022-01-31 (Crawled : 23:00) - globenewswire.com
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: 0.85%
H: 2.79%
C: 2.79%
MYMX 4 | $0.0016 0.0% 4.8M
|
Manufacturing
|
| O: -5.71%
H: 0.0%
C: 0.0%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: -0.22%
H: 2.38%
C: 2.24%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: 0.0%
PCVX | $60.82 0.33% 0.33% 1.3M
|
Health Technology
|
| O: -0.06%
H: 7.13%
C: 6.85%
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: -0.2%
H: 5.36%
C: 3.21%
grant granted pharma
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.